Option Care Health (OPCH) FY2020 results: revenue $3.0 billion, up 31.3% on the year
Option Care Health, Inc. (OPCH) reported revenue of $3.0 billion for fiscal 2020, the year ended 31 December 2020, up 31.3% on the year before. Net income was -$8 million, and diluted earnings per share $-0.04. The figures are the company's own, from the 10-K it filed with the SEC on 11 March 2021.
Revenue
$3.0 billion
+31.3% on the year
FY2008FY2020
Operating margin
3.7%
-0.0% a year earlier
FY2008FY2020
Net income
-$8 million
FY2008FY2020
Diluted EPS
-$0.04
FY2008FY2020
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Revenue
3,033
2,310
1,940
+31.3%
Cost of revenue
2,350
1,797
466
+30.8%
Gross profit
682
513
422
+33.0%
Gross margin
22.5%
22.2%
21.8%
Selling, general and administrative
500
460
346
+8.8%
Operating income
111
-0.3
38.3
Operating margin
3.7%
-0.0%
2.0%
Interest expense
108
73.7
45.8
+46.2%
Pre-tax income
-5.2
-78.2
-51.0
Income tax
2.8
-2.3
-2.7
Net income
-8.1
-75.9
-6.1
Net margin
-0.3%
-3.3%
-0.3%
Diluted EPS
-$0.04
-$0.49
-$0.49
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Operating cash flow
127
39.5
24.4
+222.8%
Capital expenditure
26.9
28.3
26.3
-5.0%
Free cash flow
101
11.2
-1.8
+799.5%
Free cash flow margin
3.3%
0.5%
-0.1%
Cash from investing
-26.3
-728
-37.0
Cash from financing
-68.8
719
-4.2
Depreciation and amortisation
71.3
53.7
38.1
+32.8%
Share-based compensation
2.9
4.2
2.1
-30.0%
Diluted shares, weighted
181m
156m
n/a
+15.8%
Shares outstanding at period end
180m
177m
128m
+1.8%
Balance sheet
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Shareholders' equity
1,016
907
603
+12.0%
Debt
1,124
1,286
539
-12.6%
Operating lease liabilities
70.8
58.2
0.0
+21.5%
Other liabilities
437
338
286
+29.2%
Total liabilities and equity
2,647
2,590
1,428
+2.2%
Fixed assets
121
133
93.1
-9.0%
Goodwill
1,429
1,426
632
+0.2%
Intangible assets
351
386
10.5
-9.0%
Cash and equivalents
99.3
67.1
36.4
+48.0%
Receivables
328
324
310
+1.2%
Inventory
159
116
83.3
+36.9%
Other assets
160
138
262
+16.6%
Total assets
2,647
2,590
1,428
+2.2%
10-K for the year ended 31 December 2020, filed 11 March 2021: the filing.